Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BASKET BALL - a Prospective, Multicenter, International, Open-label, Randomized Clinical Trial Comparing the Sirolimus-DCB Strategy vs. DES Strategy in de Novo High-risk Patients

NCT07363161 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT07363161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07363161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BASKET BALL - a Prospective, Multicenter, International, Open-label, Randomized Clinical Trial Comparing the Sirolimus-DCB Strategy vs. DES Strategy in de Novo High-risk Patients
Lead sponsor
B. Braun Melsungen AG
Phase
Not applicable
Overall status
Recruiting
Start date
June 17, 2026
Completion date
March 31, 2031
Enrollment
2,184 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)